Clarithromycin Prices in the Global Market

North America

The Clarithromycin Prices had taken an irregular trajectory in the North American region by the conclusion of the fourth quarter of 2022. In the first two months of Q4, prices were observed to be constant in the upper range due to strong market demand sentiments and favorable cost support from the operational side. Additionally, the supply-demand imbalance and regional inflation contributed to an increase in the price of Clarithromycin API. However, due to low demand and ample supply, prices began to decline later in December as inflation began to reduce. Towards the termination of Q4 2022, the values accessed at USD 261500/MT with an average quarterly inclination of 0.31%.

Asia

In the fourth quarter of 2022, the Clarithromycin API market in the Asia Pacific region took a volatile turn. At the beginning of Q4 2022, rising end-user sector demand, a number of logistical difficulties, and rising inflation influenced the prices to increase till the second month of the quarter. The strict zero covid regulations and frequent lockdowns in the Chinese regions due to the pandemic resurgence have influenced the market. Rising production costs driven by rising energy prices, as well as increased domestic production to meet demands from both domestic and international markets, kept the market situation competitive. The market remained weak later in December due to low end-user sector demand and enough inventories among the merchants. Towards the termination of Q4 2022, the values accessed at USD 206120/MT with a quarterly inclination of 0.19%

Europe

Prices for Clarithromycin API in the European region showed a see-saw tendency in the fourth quarter of 2022. In the first two months of Q4, the demand for Clarithromycin API in the downstream pharmaceutical industry was seen to be steady. The supply chain was impacted by the continuous port congestion and supply disruption in the European region, which forced an increase in pricing. High freight costs were another factor in Clarithromycin’s upward trend. Due to the impending holiday season, European retailers have decided to refill their stocks in large quantities. However, because of existing stocks and declining end-user sector demand in December, prices declined. Towards the end of Q4 2022, the prices of Clarithromycin API were recorded at USD 263660/ton with an average quarterly inclination of 0.06%.

ChemAnalyst addresses the key problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make smart choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls in an efficient and agile manner. Timeliness and accuracy of data has been the core competency of ChemAnalyst, benefitting domestic as well as global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.